Viz.ai, a San Francisco, CA- and Tel Aviv, Israel-based based provider of an intelligent care coordination system, raised $71m in Series C funding.
The round, which brought total funding to over $150m since inception, was led by Scale Venture Partners and Insight Partners with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures.
The company aims to accelerate expansion of its Intelligent Care Coordination A.I. platform beyond stroke to other areas of acute care such as cardiology, pulmonary and trauma, and into new global markets.
Led by Chris Mansi, co-founder and CEO, Viz.ai provides an AI-driven modern care coordination platform which leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat.
The company’s FDA-cleared product suite runs AI-powered real time disease detection, automated alerts and triage, mobile DICOM image viewing, HIPAA-compliant secure messaging, and point of care physician consults that enhances patient care, resulting in exceptional patient outcomes.